Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Sunday, March 24, 2013
Washington State Board of Pharmacy Compounding State of Feb. 25, 2013 Re: Office Use and Patient Specific
Compounding Statement of February 25, 2013
Washington State Board of Pharmacy
Chris Humberson, R.Ph.
The Washington State Board of Pharmacy recently discussed pharmacy compounding and specifically WAC 246-878-020(4) at their Feb 21, 2013 meeting. The board has always read (4) in conjunction with other subsections which specifically require a prescription for a compounded drug. However, they agreed that (4), read independently, could allow a pharmacy to provide compounded products for a practitioner to administer to individual patients without a prescription for a specific patient. Because this has clearly been the belief of some compounding pharmacies in Washington, the board decided it will honor this interpretation of the rule
The Board will continue the rule making process on compounding practices as voted on during their January 10, 2013 meeting to make sure pharmacy compounding is done under the appropriate standards to protect the health and safety of the people of Washington. They will involve all stakeholders in this process.
Doreen E. Beebe Program Manager Washington State Board of Pharmacy PO Box 47852 Olympia WA 98504-7852 Phone 360/236-4834 Fax 360/236-2901